Tags - PharmaBoardroomPharmaBoardroom

Romark: Heading the New Wave of Puerto Rican Pharma Manufacturing

Headquartered in Tampa, Florida, Romark focuses on developing innovative treatments for infectious diseases and the latest newcomer to Puerto Rico.…

Decision Time for APAC Pharma: Step Up or Sit Back?

Ai Hua Ong, Asia-Pacific company group chairman of Janssen, the Pharmaceutical Companies of Johnson & Johnson, looks back at the tremendous…

The Fight Against Superbugs Heats Up

Boston University School of Law’s Kevin Outterson* looks at how cost-saving measures are contributing to the rise of drug-resistant “superbugs”…

The Role of Patient Associations in Rare Disease Drug Development

Monica Weldon, CEO and president of Bridge the Gap – SYNGAP Education and Research Foundation, shares her recent experience at the US Drug Law and…

Drug Shortages in Russia: An Increasing Concern

Russia is facing a drug shortage crisis which is having a particular impact on patients with life-threatening conditions. A combination of…

The Youngest Ever Czech Health Minister’s Ambitious Reform…

The Czech Republic’s Minister of Health, Adam Vojtěch, is the youngest in the country’s history and has set out an ambitious reform…

Sweden’s Biotech Boom

Sweden is fast staking a claim as one of Europe’s premier biotech hotspots thanks to a holistic approach to research projects, a strong…

Recipharm: Sweden’s CDMO Champion

Since going public five years ago, Recipharm, Sweden’s iconic indigenous contract development and manufacturing organization (CDMO), has seen its…

Sweden’s Excellence in Cancer Care: Behind the Figures

Key stakeholders in Swedish pharma explain why Sweden’s record on cancer care is the best in Europe and what more still needs to be done.…

Pharma Faces: Mattias Perjos, Getinge

With over 110 years of existence, Getinge is a true Swedish success story. Born as a manufacturer of agricultural equipment in the small rural town on…

Saudi Arabia’s Bold Ambition to Become a Regional Pharma Hub

Saudi Arabia is aiming to become a more attractive investment destination for multinational pharma companies through economic development projects…

Pharma Faces: Paolo Carli, Merck MEAR

Paolo Carli, head of Middle East, Africa, Turkey, Russia and CIS (MEAR) for Merck has continually taken on greater responsibilities in the Middle…

Sign in

Tagged with